January 30, 2025
Rollout of the 988 suicide and crisis hotline in the United States has not led to significant and equitable growth in the availability of most mental […]
January 30, 2025
A new study released this week adds to mounting evidence that suggests climate change, with extreme hot and cold temperatures, threatens not only physical health but […]
January 30, 2025
TOPLINE: Glutamatergic drugs are associated with a significant improvement in symptoms of obsessive-compulsive and related disorders (OCRDs) compared with control treatments, a new review and meta-analysis […]
January 29, 2025
About a year ago, the US Food and Drug Administration (FDA) granted premarket approval to AvertD (SOLVD Health), the first genetic test to assess an individual’s […]
January 28, 2025
TOPLINE: In adolescent boys, exposure to violent television content during their preschool years is associated with increased levels of self-reported proactive aggression, physical aggression, and antisocial […]
January 24, 2025
The US Food and Drug Administration (FDA) has approved a supplemental new drug application allowing esketamine nasal spray (Spravato; Johnson & Johnson) to be used as […]
January 24, 2025
TOPLINE: Increased loneliness during adolescence is associated with various health and well-being outcomes, including an increased risk for asthma and depression, in adulthood. METHODOLOGY: Researchers conducted […]
January 23, 2025
A diagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults was associated with a 7-year reduction in life expectancy, on average, compared to the general population, findings from […]
January 23, 2025
TOPLINE: Buprenorphine dispensing for opioid use disorder (OUD) increased among US adolescents but decreased among young adults between 2020 and 2023, with overall dispensing declining 6.5% […]